Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study

By Portenoy Russell K.   Messina John   Xie Fang   Peppin John  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-01 ,pp. : 223-233

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain

By Rauck Richard L.   Tark Marvin   Reyes Eva   Hayes Teresa G.   Bartkowiak Anthony J.   Hassman David   Nalamachu Srinivas   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2877-2885

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain

By Nalamachu Srinivas   Hassman David   Wallace Mark S.   Dumble Sam   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 519-530

Informa Healthcare

Access to resources Recommend Favorite

Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain

By ÜÜberall Michael A.   Müüller-Schwefe Gerhard H.H.  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1385-1394

Informa Healthcare

Access to resources Recommend Favorite

Fentanyl for Breakthrough Cancer Pain: Where are We?

By  

Reviews on Recent Clinical Trials, Vol. 8, Iss. 1, 2013-03 ,pp. : 42-47

Bentham Science Publishers

Access to resources Recommend Favorite